COMT haplotypes suggest P2 promoter region relevance for schizophrenia

Molecular Psychiatry

Volumn 9, Issue 9, 2004, Pages 859-870

  Palmatier, M A ^a   Pakstis, A J ^a   Speed, W ^a   Paschou, P ^a   Goldman, D ^b   Odunsi, A ^c   Okonofua, F ^d   Kajuna, S ^e   Karoma, N ^e   Kungulilo, S ^f   Grigorenko, E ^g   Zhukova, O V ^h   Bonne Tamir, B ⁱ   Lu, R B ^j   Parnas, J ^k   Kidd, J R ^a   DeMille, M M C ^a   Kidd, K K ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^c ROSWELL PARK CANCER INSTITUTE   (United States)

^d UNIVERSITY OF BENIN   (Nigeria)

^e HUBERT KAIRUKI MEMORIAL UNIVERSITY   (Tanzania)

^f MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

^g YALE UNIVERSITY   (United States)

^h VAVILOV INSTITUTE OF GENERAL GENETICS   (Russian Federation)

ⁱ TEL AVIV UNIVERSITY   (Israel)

^j TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^k UNIVERSITY OF COPENHAGEN   (Denmark)

more..

Author keywords

COMT; Functional variation; Haplotypes; Linkage disequilibrium; P2 promoter; Population variation; Schizophrenia

Indexed keywords

CATECHOL METHYLTRANSFERASE; CIS ACTING ELEMENT; COMPLEMENTARY DNA; METHIONINE; VALINE;

ARTICLE; DNA FLANKING REGION; EXON; GENE FREQUENCY; GENE LOCATION; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; JEW; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION SITE; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

CATECHOL O-METHYLTRANSFERASE; DATABASES, GENETIC; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; PROMOTER REGIONS (GENETICS); SCHIZOPHRENIA; VARIATION (GENETICS);

EID: 4644248763     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mp.4001496     Document Type: Article

References (33)

1. Shifman S, Bronstein M, Sternfeld M, Pisante-Shalom A, Lev-Lehman E, Weizman A et al. A highly significant association between a COMT haplotype and schizophrenia. Am J Hum Genet 2002; 71: 1296-1302.
2. Bray NJ, Buckland PR, Williams NM, Williams HJ, Norton N, Owen MJ et al. A haplotype implicated in schizophrenia susceptibility is associated with reduced COMT expression in human brain. Am J Hum Genet 2003; 73: 152-161.
3. DeMille MM, Kidd JR, Ruggeri V, Palmatier MA, Goldman D, Odunsi A et al. Population variation in linkage disequilibrium across the COMT gene considering promoter region and coding region variation. Hum Genet 2002; 111: 521-537.
4. Li T, Ball D, Zhao J, Murray RM, Liu X, Sham PC et al. Family-based linkage disequilibrium mapping using SNP marker haplotypes: application to a potential locus for schizophrenia at chromosome 22q11. Mol Psychiatry 2000; 5: 77-84.
5. Li T, Ball D, Zhao J, Murray RM, Liu X, Sham PC et al. Errata: Family-based linkage disequilibrium mapping using SNP marker haplotypes: application to a potential locus for schizophrenia at chromosome 22q11. Mol Psychiatry 2000; 5: 452.
6. Egan MF, Goldberg TE, Kolachana BS, Callicott JH, Mazzanti CM, Straub RE et al. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci USA 2001; 98: 6917-6922.
7. Bilder RM, Volavka J, Czobor P, Malhotra AK, Kennedy JL, Ni X et al. Neurocognitive correlates of the COMT Val(158)Met polymorphism in chronic schizophrenia. Biol Psychiatry 2002; 52: 701-707.
8. Murphy KC, Jones LA, Owen MJ. High rates of schizophrenia in adults with velo-cardio-facial syndrome. Arch Gen Psychiatry 1999; 56: 940-945.
9. Karoum F, Chrapusta SJ, Egan MF. 3-Methoxytyramine is the major metabolite of released dopamine in the rat frontal cortex: reassessment of the effects of antipsychotics on the dynamics of dopamine release and metabolism in the frontal cortex, nucleus accumbens, and striatum by a simple two pool model. J Neurochem 1994; 63: 972-979.
10. Sklar P. Linkage analysis in psychiatric disorders: the emerging picture. Annu Rev Genomics Hum Genet 2002; 3: 371-413.
11. O'Donovan MC, Williams NM, Owen MJ. Recent advances in the genetics of schizophrenia. Hum Mol Genet 2003; 12: R125-R133.
12. Maier W, Zobel A, Rietschel M. Genetics of schizophrenia and affective disorders. Pharmacopsychiatry 2003; 36(Suppl 3): 195-202.
13. Pulver AE. Search for schizophrenia susceptibility genes. Biol Psychiatry 2000; 47: 221-230.
14. Riley BP, McGuffin P. Linkage and associated studies of schizophrenia. Am J Med Genet 2000; 97: 23-44.
15. Williams NM, Norton N, Williams H, Ekholm B, Hamshere ML, Lindblom Y et al. A systematic genomewide linkage study in 353 sib pairs with schizophrenia. Am J Hum Genet 2003; 73: 1355-1367.
16. Bertocci B, Miggiano V, Da Prada M, Dembic Z, Lahm HW, Malherbe P. Human catechol-O-methyltransferase: cloning and expression of the membrane-associated form. Proc Natl Acad Sci USA 1991; 88: 1416-1420.
17. Tenhunen J, Salminen M, Lundstrom K, Kiviluoto T, Savolainen R, Ulmanen I. Genomic organization of the human catechol O-methyltransferase gene and its expression from two distinct promoters. Eur J Biochem 1994; 223: 1049-1059.
18. Lundstrom K, Tenhunen J, Tilgmann C, Karhunen T, Panula P, Ulmanen I. Cloning, expression and structure of catechol-O-methyltransferase. Biochim Biophys Acta 1995; 1251: 1-10.
19. Palmatier MA, Kang AM, Kidd KK. Global variation in the frequencies of functionally different catechol-O-methyl transferase alleles. Biol Psychiatry 1999; 46: 557-567.
20. Matsumoto M, Weickert CS, Beltaifa S, Kolachana B, Chen J, Hyde TM et al. Catechol O-methyltransferase (COMT) mRNA expression in the dorsolateral prefrontal cortex of patients with schizophrenia. Neuropsychopharmacology 2003; 28: 1521-1530.
21. Tunbridge E, Burnet PWJ, Sodhi S, Harrision PJ. Catechol-O- methyltransferase (COMT) and proline dehydrogenase (PRODH) mRNAs in the dorsolateral prefrontal cortex in schizophrenia, bipolar disorder, and major depression. Synapse 2004; 51: 112-118.
22. Iyengar S, Seaman M, Deinard AS, Rosenbaum HC, Sirugo G, Castiglione CM et al. Analyses of cross species polymerase chain reaction products to infer the ancestral state of human polymorphisms. DNA Seq 1998; 8: 317-327.
23. Hawley ME, Kidd KK. HAPLO: a program using the EM algorithm to estimate the frequencies of multi-site haplotypes. J Hered 1995; 86: 409-411.
24. Lewontin R. The interaction of selection and linkage. I. General considerations: heterotic models. Genetics 1964; 49: 49-67.
25. Zhao H, Pakstis AJ, Kidd JR, Kidd KK. Assessing linkage disequilibrium in a complex genetic system. I. Overall deviation from random association. Ann Hum Genet 1999; 63: 167-179.
26. Devlin B, Risch N. A comparison of linkage disequilibrium measures for fine-scale mapping. Genomics 1995; 29: 311-322.
27. Pakstis AJ, Kidd JR, Kidd KK. A reference distribution of Fst values for biallelic DNA markers. Am J Hum Genet 2002; 71(Suppl): 371.
28. Calafell F, Grigorenko EL, Chikanian AA, Kidd KK. Haplotype evolution and linkage disequilibrium: a simulation study. Hum Hered 2001; 51: 85-96.
29. Matsumoto M, Weickert CS, Akil M, Lipska BK, Hyde TM, Herman MM et al. Catechol O-methyltransferase mRNA expression in human and rat brain: evidence for a role in cortical neuronal function. Neuroscience 2003; 116: 127-137.
30. Lotta T, Vidgren J, Tilgmann C, Ulmanen I, Melen K, Julkunen I et al. Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme. Biochemistry 1995; 34: 4202-4210.
31. Wonodi I, Stine OC, Mitchell BD, Buchanan RW, Thaker GK. Association between Val108/158 Met polymorphism of the COMT gene and schizophrenia. Am J Med Genet 2003; 120B: 47-50.
32. Strous RD, Nolan KA, Lapidus R, Diaz L, Saito T, Lachman HM. Aggressive behavior in schizophrenia is associated with the low enzyme activity COMT polymorphism: a replication study. Am J Med Genet 2003; 120B: 29-34.
33. Inada T, Nakamura A, Iijima Y. Relationship between catechol-O- methyltransferase polymorphism and treatment-resistant schizophrenia. Am J Med Genet 2003; 120B: 35-39.